Ristau, J.
Hörner-Rieber, J.
Buchele, C.
Klüter, S.
Jäkel, C.
Baumann, L.
Andratschke, N.
Garcia Schüler, H.
Guckenberger, M.
Li, M.
Niyazi, M.
Belka, C.
Herfarth, K.
Debus, J.
Koerber, S. A.
Funding for this research was provided by:
ViewRay
Universitätsklinikum Heidelberg
Article History
Received: 17 February 2022
Accepted: 31 March 2022
First Online: 15 April 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: JHR and S.K. received speaker fees and travel reimbursement from ViewRay Inc. JHR received travel reimbursement from IntraOP Medical and Elekta Instrument AB outside the submitted work. JHR further reports a research grant from IntraOP Medical outside the submitted work. JD and SAK report research grants from Viewray Inc. JD received grants from CRI The Clinical Research Institute GmbH, from Accuray Incorporated, Accuray International Sàrl, from RaySearch Laboratories AB, from Vision RT Limited, from Merck Serono GmbH, from Astellas Pharma GmbH, from Astra Zeneca GmbH, from Siemens Healthcare GmbH, from Solution Akademie GmbH, from Egomed PLC Surrey Research Park, from Quintiles GmbH, from Pharmaceutical Research Associates GmbH, from Boehringer Ingelheim Pharma GmbH&CoKG, from PTW-Freiburg Dr. Pychlau GmbH, from Nanobiotix S.A. and IntraOP Medical, outside the submitted work. KH reports grants from Roche Pharma AG outside the submitted work. SAK reports honoraria from IBA dosimetry, outside the submitted work.